129 related articles for article (PubMed ID: 27058979)
1. Levosimendan reduces myocardial damage and improves cardiodynamics in streptozotocin induced diabetic cardiomyopathy via SERCA2a/NCX1 pathway.
Akhtar MS; Pillai KK; Hassan MQ; Dhyani N; Ismail MV; Najmi AK
Life Sci; 2016 May; 153():55-65. PubMed ID: 27058979
[TBL] [Abstract][Full Text] [Related]
2. Levosimendan suppresses oxidative injury, apoptotic signaling and mitochondrial degeneration in streptozotocin-induced diabetic cardiomyopathy.
Akhtar MS; Pillai KK; Hassan Q; Ansari SH; Ali J; Akhtar M; Najmi AK
Clin Exp Hypertens; 2016; 38(1):10-22. PubMed ID: 26207881
[TBL] [Abstract][Full Text] [Related]
3. EGFR tyrosine kinase inhibition decreases cardiac remodeling and SERCA2a/NCX1 depletion in streptozotocin induced cardiomyopathy in C57/BL6 mice.
Shah S; Akhtar MS; Hassan MQ; Akhtar M; Paudel YN; Najmi AK
Life Sci; 2018 Oct; 210():29-39. PubMed ID: 30107170
[TBL] [Abstract][Full Text] [Related]
4. [Mechanism of reversion of myocardial interstitial fibrosis in diabetic cardiomyopathy by valsartan].
Zhong M; Zhang Y; Miao Y; Li L; Gong HP; Ma X; Sun H; Zhang W
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):232-6. PubMed ID: 16677501
[TBL] [Abstract][Full Text] [Related]
5. [Activation of transforming growth factor-beta1/Smads signal pathway in diabetic cardiomyopathy and effects of valsartan thereon: experiment with rats].
Miao Y; Zhang W; Zhong M; Ma X; Qi TG; Sun H
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):366-70. PubMed ID: 17456374
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of levosimendan during rewarming from hypothermia in rat.
Dietrichs ES; Håheim B; Kondratiev T; Sieck GC; Tveita T
Cryobiology; 2014 Dec; 69(3):402-10. PubMed ID: 25280932
[TBL] [Abstract][Full Text] [Related]
7. Ca2+ sensitizer superior to catecholamine during myocardial stunning?
Meyer K; Klocke RC; Schipke JD; Gams E; Korbmacher B
Eur J Cardiothorac Surg; 2008 Aug; 34(2):326-31. PubMed ID: 18539040
[TBL] [Abstract][Full Text] [Related]
8. Levosimendan improves cardiac function and survival in rats with angiotensin II-induced hypertensive heart failure.
Biala A; Martonen E; Kaheinen P; Levijoki J; Finckenberg P; Merasto S; Louhelainen M; Muller DN; Luft FC; Mervaala E
Hypertens Res; 2010 Oct; 33(10):1004-11. PubMed ID: 20811386
[TBL] [Abstract][Full Text] [Related]
9. Oral levosimendan prevents postinfarct heart failure and cardiac remodeling in diabetic Goto-Kakizaki rats.
Louhelainen M; Vahtola E; Forsten H; Merasto S; Kytö V; Finckenberg P; Leskinen H; Kaheinen P; Tikkanen I; Levijoki J; Mervaala E
J Hypertens; 2009 Oct; 27(10):2094-107. PubMed ID: 19730126
[TBL] [Abstract][Full Text] [Related]
10. Total triterpene acids, active ingredients from Fructus Corni, attenuate diabetic cardiomyopathy by normalizing ET pathway and expression of FKBP12.6 and SERCA2a in streptozotocin-rats.
Qi MY; Liu HR; Dai DZ; Li N; Dai Y
J Pharm Pharmacol; 2008 Dec; 60(12):1687-94. PubMed ID: 19000375
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the sarcoplasmic reticulum Ca(2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy.
Trost SU; Belke DD; Bluhm WF; Meyer M; Swanson E; Dillmann WH
Diabetes; 2002 Apr; 51(4):1166-71. PubMed ID: 11916940
[TBL] [Abstract][Full Text] [Related]
12. The calcium sensitizer levosimendan attenuates endotoxin-evoked myocardial dysfunction in isolated guinea pig hearts.
Behrends M; Peters J
Intensive Care Med; 2003 Oct; 29(10):1802-7. PubMed ID: 12879240
[TBL] [Abstract][Full Text] [Related]
13. Long-term levosimendan treatment improves systolic function and myocardial relaxation in mice with cardiomyocyte-specific disruption of the Serca2 gene.
Hillestad V; Kramer F; Golz S; Knorr A; Andersson KB; Christensen G
J Appl Physiol (1985); 2013 Nov; 115(10):1572-80. PubMed ID: 24072410
[TBL] [Abstract][Full Text] [Related]
14. Effects of levosimendan on cardiac remodeling and cardiomyocyte apoptosis in hypertensive Dahl/Rapp rats.
Louhelainen M; Vahtola E; Kaheinen P; Leskinen H; Merasto S; Kytö V; Finckenberg P; Colucci WS; Levijoki J; Pollesello P; Haikala H; Mervaala EM
Br J Pharmacol; 2007 Apr; 150(7):851-61. PubMed ID: 17325658
[TBL] [Abstract][Full Text] [Related]
15. The effect of levosimendan on lung damage after myocardial ischemia reperfusion in rats in which experimental diabetes was induced.
Alkan M; Çelik A; Bilge M; Kiraz HA; Kip G; Özer A; Şıvgın V; Erdem Ö; Arslan M; Kavutçu M
J Surg Res; 2015 Feb; 193(2):920-5. PubMed ID: 25288204
[TBL] [Abstract][Full Text] [Related]
16. Azelnidipine prevents cardiac dysfunction in streptozotocin-diabetic rats by reducing intracellular calcium accumulation, oxidative stress and apoptosis.
Kain V; Kumar S; Sitasawad SL
Cardiovasc Diabetol; 2011 Nov; 10():97. PubMed ID: 22054019
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective effects of hydroxysafflor yellow A on diabetic cardiac insufficiency attributed to up-regulation of the expression of intracellular calcium handling proteins of sarcoplasmic reticulum in rats.
He H; Liu Q; Shi M; Zeng X; Yang J; Wu L; Li L
Phytother Res; 2008 Aug; 22(8):1107-14. PubMed ID: 18570267
[TBL] [Abstract][Full Text] [Related]
18. Compound SJ-12 attenuates streptozocin-induced diabetic cardiomyopathy by stabilizing SERCA2a.
Lou S; Zhu W; Yu T; Zhang Q; Wang M; Jin L; Xiong Y; Xu J; Wang Q; Chen G; Liang G; Hu X; Luo W
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167140. PubMed ID: 38548092
[TBL] [Abstract][Full Text] [Related]
19. IGF-I attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes.
Norby FL; Wold LE; Duan J; Hintz KK; Ren J
Am J Physiol Endocrinol Metab; 2002 Oct; 283(4):E658-66. PubMed ID: 12217882
[TBL] [Abstract][Full Text] [Related]
20. Urocortin attenuates myocardial fibrosis in diabetic rats via the Akt/GSK-3β signaling pathway.
Liu X; Liu C; Li J; Zhang X; Song F; Xu J
Endocr Res; 2016 May; 41(2):148-57. PubMed ID: 26934363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
